Addex Therapeutics Reports Q1 2025 Financial Results and Provides Corporate Update
June 19, 2025 01:00 ET | Source: Addex Therapeutics Strong cash position…
THE COUNTDOWN IS ON: TWO WEEKS TO GO UNTIL HUBLOT STARTS THE CLOCK ON UEFA WOMEN’S EURO 2025
FOOTBALL COMES TO SWITZERLAND THIS SUMMER WITH THE UEFA WOMEN'S EURO 2025™.…
Addex Therapeutics to Release Q1 2025 Financial Results and Host Conference Call on June 19, 2025
June 18, 2025 01:00 ET | Source: Addex Therapeutics Geneva, Switzerland, June…
IOC Executive Board meeting 2526 June 2025 Information for the media
17 June 2025 - Following the handover of the Presidency of the International…
SmartLabs and IWG Announce 10-Year Partnership to Deliver Fully Managed Lab Infrastructure Worldwide
First-of-its-kind collaboration will integrate SmartLabs' turnkey laboratory solutions across IWG's global portfolio…
GENESIS ANNOUNCES MAJOR EUROPEAN MARKET EXPANSION AT LE MANS
Genesis Motor Europe will expand operations into four new marketsThe Korean car…
International Athletes’ Forum 2025 empowers and inspires over 400 athlete representatives
12 June 2025 - More than 400 athlete representatives gathered in Lausanne, Switzerland,…
Information for the media IOC Presidential Handover Ceremony
10 June 2025 - The International Olympic Committee (IOC) will mark a historic…
A programme focused on sharing, collaborating and confirming action
06 June 2025 – The voices of 29 IOC Young Leaders resonated powerfully at…
Alvotech has carried out a private placement of 7,500,000 SDRs and ordinary shares at a price of SEK 100.00 per SDR and ISK 1320.83 per ordinary share, raising gross proceeds of SEK 750 million
THIS PRESS RELEASE MAY NOT BE DISTRIBUTED, RELEASED, OR PUBLISHED, DIRECTLY OR…